Thrombolex, Inc.

Founded in 2016, Thrombolex, Inc. is engaged in the design, development, manufacture and distribution of innovative endovascular catheters used in interventional procedures, particularly in catheter-directed thrombolysis (CDT) of thrombus in patients affected by A+VTE conditions. A recent comprehensive scientific review revealed that 10 million cases of venous thromboembolism (VTE) occur annually on a worldwide basis with significant mortality and morbidity.